"#",Jurisdiction,Kind,Display Key,Lens ID,Publication Date,Publication Year,Application Number,Application Date,Priority Numbers,Earliest Priority Date,Title,Abstract,Applicants,Inventors,Owners,URL,Document Type,Has Full Text,Cites Patent Count,Cited by Patent Count,Simple Family Size,Extended Family Size,Sequence Count,CPC Classifications,IPCR Classifications,US Classifications,NPL Citation Count,NPL Resolved Citation Count,NPL Resolved Lens ID(s),NPL Resolved External ID(s),NPL Citations,Legal Status
1,US,B2,US 11376421 B2,198-394-245-478-199,2022-07-05,2022,US 201816762542 A,2018-11-09,US 201816762542 A;;US 201762583778 P;;US 2018/0059993 W,2017-11-09,Neurostimulation induced medicine devices and related methods of use,"Example neurostimulation induced medicine devices and methods of use are described herein. An example endotracheal device can include an elongate tubular member having a proximal end and a distal end, an inflatable cuff arranged between the proximal and distal ends of the elongate tubular member, and an electrode array disposed in proximity to an exterior surface of the inflatable cuff. The inflatable cuff can be configured to expand to contact a subject's tracheal wall. Additionally, the electrode array can include a plurality of flexible electrodes, where a set of the flexible electrodes anatomically align with a region of the subject's tracheal wall for selectively targeting vagus nerve activity.",THE METHODIST HOSPITAL SYSTEM,GOLANOV EUGENE V;;BRITZ GAVIN W;;HORNER PHILIP JOHN;;WOLFE TATIANA,THE METHODIST HOSPITAL SYSTEM (2020-09-25),https://lens.org/198-394-245-478-199,Granted Patent,yes,12,0,3,3,0,A61N1/0517;;A61N1/36053;;A61M16/045;;A61N1/3614;;A61N1/086;;A61M16/0488;;A61N1/0519;;A61N1/36053,A61N1/05;;A61M16/04;;A61N1/04;;A61N1/08;;A61N1/36,,57,48,058-137-008-937-423;;033-513-513-478-52X;;095-187-534-875-047;;002-085-009-779-822;;113-775-688-846-945;;028-610-534-683-403;;006-270-031-475-219;;028-941-595-488-595;;064-758-894-023-683;;030-985-209-793-644;;049-750-368-075-635;;048-657-279-219-518;;067-093-113-718-534;;081-100-074-022-795;;008-058-387-820-794;;055-790-693-684-980;;027-560-114-011-29X;;094-199-126-640-726;;080-439-088-180-563;;008-257-934-297-78X;;065-217-348-956-712;;008-762-077-464-674;;015-965-357-786-604;;029-713-884-789-580;;042-952-860-975-169;;017-222-389-226-463;;163-816-077-582-76X;;090-670-816-897-058;;012-930-875-324-494;;005-399-115-705-625;;075-932-393-898-457;;036-008-907-660-940;;019-745-799-387-636;;017-735-414-964-227;;066-374-577-714-608;;009-951-657-405-768;;061-028-087-830-24X;;039-479-032-331-596;;017-662-908-391-380;;037-823-435-133-567;;003-222-807-105-94X;;055-618-799-838-445;;008-250-614-383-820;;030-713-302-131-080;;053-103-767-537-159;;019-857-638-000-724;;150-109-574-550-545;;046-595-744-593-502,10.1007/s00380-010-0108-y;;21240508;;10.1016/j.brs.2015.11.008;;26723020;;pmc4789082;;10.1016/j.brs.2014.09.009;;pmc4277719;;25312600;;25009531;;10.3389/fneur.2014.00107;;pmc4067569;;10.1016/j.mehy.2013.10.005;;24176140;;10.1097/ana.0000000000000065;;25602626;;10.5137/1019-5149.jtn.7114-12.1;;24101263;;pmc4657244;;10.1186/s12920-015-0155-4;;26597292;;10.1152/ajpheart.1998.274.6.h2035;;9841530;;10.1016/j.brainres.2003.08.001;;14642639;;10.1016/s0006-8993(01)02602-6;;11520492;;pmc6782716;;10.1523/jneurosci.19-10-04142.1999;;10234042;;10320711;;10.1016/s0006-8993(99)01256-1;;10082816;;10.1016/s0006-8993(98)01169-x;;10.1023/a:1025088516742;;14514022;;10.1097/00001756-199803300-00010;;9579672;;10.3389/fneur.2016.00157;;pmc5030511;;27708614;;10526150;;10.1016/s0006-8993(99)01871-5;;23684083;;10.1016/s1474-4422(13)70091-7;;17761922;;10.1161/strokeaha.107.485581;;10.1002/jnr.22812;;pmc3306061;;22420043;;25678279;;pmc6495401;;10.1111/cns.12383;;10.1016/j.neuint.2016.02.009;;26964767;;pmc4103831;;25036185;;10.1371/journal.pone.0102342;;22404761;;10.3109/02688697.2012.663517;;28754973;;10.1038/s41598-017-07219-3;;pmc5533766;;23597434;;pmc3861344;;10.1016/s0003-4975(97)00423-2;;9203592;;pmc4602726;;25654391;;10.1097/md.0000000000000484;;10.1097/00001756-200310270-00018;;14561931;;26399249;;10.1007/s12028-015-0203-0;;25783478;;10.1111/jnc.13094;;24670857;;10.1097/sla.0000000000000328;;10.1016/s0006-8993(97)01017-2;;9497093;;10.1111/j.1749-6632.1997.tb48628.x;;9616772;;10.1038/sj.jcbfm.9591524.0303;;10.1586/ern.11.198;;22288672;;10.15406/jnsk.2015.02.00067;;pmc4365063;;10.2119/molmed.2014.00147;;25299421;;10.1016/j.brs.2011.01.009;;pmc3264742;;22037134;;pmc4446308;;26016630;;10.1371/journal.pone.0128447;;24930936;;pmc6493166;;10.1111/cns.12288;;10.1111/micc.12177;;25351102;;pmc4424749;;10.4103/1673-5374.155430;;26170817;;28315868;;10.1159/000467940;;pmc4211199;;10.4103/1673-5374.141783;;25368644;;11677261;;10.1046/j.1471-4159.2001.00585.x;;16181426;;10.1111/j.1471-4159.2005.03358.x,"International Search Report and Written Opinion in PCT/US2018/059993, dated Jan. 22, 2019. 8 pages.;;Abulaiti, Alimujiang, et al. “Influence of fastigial nucleus stimulation on heart rate variability of surgically induced myocardial infarction rats: fastigial nucleus stimulation and autonomous nerve activity.” Heart and vessels 26.6 (2011): 654-662.;;Ay, Ilknur, et al. “Transcutaneous cervical vagus nerve stimulation ameliorates acute ischemic injury in rats.” Brain stimulation 9.2 (2016): 166-173.;;Ay, Ilknur, Vitaly Napadow, and Hakan Ay. “Electrical stimulation of the vagus nerve dermatome in the external ear is protective in rat cerebral ischemia.” Brain stimulation 8.1 (2015): 7-12.;;Cai, Peter Y., et al. “Vagus nerve stimulation in ischemic stroke: old wine in a new bottle.” Frontiers in neurology 5 (2014): 107.;;Chen, Ning, et al. “Neuroprotective effects of vagus nerve stimulation on hippocampal neurons in intractable epilepsy.” Medical hypotheses 81.6 (2013): 1066-1068.;;Chowdhury T, Mendelowith D, Golanov E, Spiriev T, Arasho B, Sandu N, Sadr-Eshkevari P, Meuwly C, Schaller B. Trigeminocardiac reflex: the current clinical and physiological knowledge. J Neurosurg Anesthesiol. 2015;27(2):136-47. Epub Jan. 21, 2015. doi:10.1097/ana.0000000000000065. PubMed PMID: 25602626.;;Ekici, Fatih, et al. “The effects of vagal nerve stimulation in focal cerebral ischemia and reperfusion model.” Turkish neurosurgery 23.4 (2013): 451-457.;;Feng, Ling-Bo, et al. “MicroRNA involvement in mechanism of endogenous protection induced by fastigial nucleus stimulation based on deep sequencing and bioinformatics.” BMC medical genomics 8.1 (2015): 79, 1-9.;;Galea, Elena, et al. “Cerebellar stimulation reduces inducible nitric oxide synthase expression and protects brain from ischemia.” American Journal of Physiology-Heart and Circulatory Physiology 274.6 (1998): H2035-H2045.;;Galea, Elena, et al. “Stimulation of cerebellar fastigial nucleus inhibits interleukin-1β-induced cerebrovascular inflammation.” American Journal of Physiology-Heart and Circulatory Physiology 275.6 (1998): H2053-H2063.;;Glickstein, Sara B., Christopher P. Ilch, and Eugene V. Golanov. “Electrical stimulation of the dorsal periaqueductal gray decreases volume of the brain infarction independently of accompanying hypertension and cerebrovasodilation.” Brain research 994.2 (2003): 135-145.;;Glickstein, Sara B., et al. “Stimulation of the subthalamic vasodilator area and fastigial nucleus independently protects the brain against focal ischemia.” Brain research 912.1 (2001): 47-59.;;Glickstein, Sara B., Eugene V. Golanov, and Donald J. Reis. “Intrinsic neurons of fastigial nucleus mediate neurogenic neuroprotection against excitotoxic and ischemic neuronal injury in rat.” Journal of Neuroscience 19.10 (1999): 4142-4154.;;Golanov E, Chen B, Shiflett JM, Esposito E, Parent A. Uncoupling protein 4: possible involvement in neurogenic neuroprotection. FASEB. 2003, A1069.;;Golanov E, Li C, Britz GW, Narayan RK. Early Trigeminal Nerve Stimulation Reduces Brain Edema and Lesion Volumes Following Traumatic Brain Injury. AANS. 2016, 23544.;;Golanov EV, Sitton M, Shiflett MJ, Parent AD. Diving response is neuroprotective. Society for Neuroscience. 2004:821.7.;;Golanov, Eugene V., and Donald J. Reis. “A role for KATP+-channels in mediating the elevations of cerebral blood flow and arterial pressure by hypoxic stimulation of oxygen-sensitive neurons of rostral ventrolateral medulla.” Brain research 827.1-2 (1999): 210-214.;;Golanov, Eugene V., and Donald J. Reis. “Neuroprotective electrical stimulation of cerebellar fastigial nucleus attenuates expression of periinfarction depolarizing waves (PIDs) and inhibits cortical spreading depression.” Brain research 818.2 (1999): 304-315.;;Golanov, Eugene V., and Ping Zhou. “Neurogenic neuroprotection.” Cellular and molecular neurobiology 23.4 (2003): 651-663.;;Golanov, Eugene V., Fang Liu, and Donald J. Reis. “Stimulation of cerebellum protects hippocampal neurons from global ischemia.” Neuroreport 9.5 (1998): 819-824.;;Golanov, Eugene V., James M. Shiflett, and Gavin W. Britz. “Diving response in rats: role of the subthalamic vasodilator area.” Frontiers in neurology 7 (2016): 157.;;Golanov, Eugene V., John D. Christensen, and Donald J. Reis. “Role of potassium channels in the central neurogenic neuroprotection elicited by cerebellar stimulation in rat.” Brain research 842.2 (1999): 496-500.;;Goldstein KR, Golanov EV, Iadecola C, Anrather J. Fastigial Nucleus Stimulation increases BrdU Immunoreactivity in the Paraventricular Nucleus of the Rat. Society for Neuroscience. 2002:230.11.;;Hennerici, Michael G., Rolf Kern, and Kristina Szabo. “Non-pharmacological strategies for the treatment of acute ischaemic stroke.” The Lancet Neurology 12.6 (2013): 572-584.;;Henninger, Nils, and Marc Fisher. “Stimulating circle of Willis nerve fibers preserves the diffusion-perfusion mismatch in experimental stroke.” Stroke 38.10 (2007): 2779-2786.;;Hiraki, Teruyuki, Wesley Baker, and Joel H. Greenberg. “Effect of vagus nerve stimulation during transient focal cerebral ischemia on chronic outcome in rats.” Journal of neuroscience research 90.4 (2012): 887-894.;;Huang, Li-Gang, et al. “Micro RNA-29c Correlates with Neuroprotection Induced by FNS by Targeting Both Birc2 and Bak 1 in Rat Brain after Stroke.” CNS neuroscience & therapeutics 21.6 (2015): 496-503.;;Jiang, Ying, et al. “Auricular vagus nerve stimulation promotes functional recovery and enhances the post-ischemic angiogenic response in an ischemia/reperfusion rat model.” Neurochem Int. 2016;97:73-82. Epub Mar. 12, 2016. doi:10.1016/j.neuint.2016.02.009. PubMed PMID: 26964767.;;Jiang, Ying, et al. “PPARγ upregulation induced by vagus nerve stimulation exerts anti-inflammatory effect in cerebral ischemia/reperfusion rats.” Medical science monitor: international medical journal of experimental and clinical research 21 (2015): 268.;;Jiang, Ying, et al. “Vagus nerve stimulation attenuates cerebral ischemia and reperfusion injury via endogenous cholinergic pathway in rat.” PloS one 9.7 (2014) e102342.;;Kumaria, Ashwin, and Christos M. Tolias. “Is there a role for vagus nerve stimulation therapy as a treatment of traumatic brain injury?.” British journal of neurosurgery 26.3 (2012): 316-320.;;Li C, Golanov E, Mehan N, Narayan RK. Neuroprotective effects of trigeminal nerve stimulation in traumatic brain injury. MHSRS. 2015. 7:6792.;;Liu, Bin, et al. “Electrical stimulation of cerebellar fastigial nucleus protects against cerebral ischemic injury by PPARγ upregulation.” Neurological research 39.1 (2017): 23-29.;;Mandel, Mauricio, et al. “Neurogenic neuroprotection: clinical perspectives.” Functional neurology 27.4 (2012): 207.;;Matheny, Robert G., and Carl J. Shaar. “Vagus nerve stimulation as a method to temporarily slow or arrest the heart.” The Annals of thoracic surgery 63.6 (1997): S28-S29. Abstract.;;Meuwly, C., et al. “Trigeminal cardiac reflex: new thinking model about the definition based on a literature review.” Medicine 94.5 (2015), e484.;;Miyamoto, Osamu, et al. “Mechanisms of the anti-ischemic effect of vagus nerve stimulation in the gerbil hippocampus.” Neuroreport 14.15 (2003): 1971-1974.;;Nalls T, Garabedian R, Wallace M, Golanov E. Stimulation of sphenopalatine ganglion (SPG) decreases volume of the infarction triggered by permanent middle cerebral artery occlusion (MCAO). Society for Neuroscience. 2005:702.10.;;Neren, Daniel, et al. “Vagus nerve stimulation and other neuromodulation methods for treatment of traumatic brain injury.” Neurocritical care 24.2 (2016): 308-319.;;Pang, Xiao-Min, et al. “Fastigial nucleus stimulation regulates neuroprotection via induction of a novel micro RNA, rno-miR-676-1, in middle cerebral artery occlusion rats.” Journal of neurochemistry 133.6 (2015): 926-934.;;Qi, Lei, et al. “Ghrelin protects rats against traumatic brain injury and hemorrhagic shock through upregulation of UCP2.” Annals of Surgery 260.1 (2014): 169-178.;;Reis, Donald J., et al. “Brief electrical stimulation of cerebellar fastigial nucleus conditions long-lasting salvage from focal cerebral ischemia: conditioned central neurogenic neuroprotection.” Brain research 780.1 (1998): 161-165.;;Reis, Donald J., et al. “Central neurogenic neuroprotection: central neural systems that protect the brain from hypoxia and ischemia.” Annals of the New York Academy of Sciences 835.1 (1997): 168-186.;;Rollins, Shadon, Betty Chen, and Eugene Golanov. “Possible role of cerebellar fastigial nucleus in preconditioned neuroprotection.” Journal of Cerebral Blood Flow & Metabolism (2005):334.;;Schellinger, Peter D., and Martin Köhrmann. “Current acute stroke trials and their potential impact on the therapeutic time window.” Expert review of neuro therapeutics 12.2 (2012): 169-177.;;Shiflett, J. M., A. D. Parent, and E. V. Golanov. “Forehead stimulation decreases volume of the infarction triggered by permanent occlusion of middle cerebral artery in rats.” J Neurol Stroke 2.00067 (2015): 10-15406.;;Silverman, Harold A., et al. “Brain region-specific alterations in the gene expression of cytokines, immune cell markers and cholinergic system components during peripheral endotoxin-induced inflammation.” Molecular medicine 20.1 (2014): 601-611.;;Sun, Zhenghui, et al. “The effect of right vagus nerve stimulation on focal cerebral ischemia: an experimental study in the rat.” Brain stimulation 5.1 (2012): 1-10.;;Tang, Weiju, et al. “The effect of pre-condition cerebella fastigial nucleus electrical stimulation within and beyond the time window of thrombolytic on ischemic stroke in the rats.” PloS one 10.5 (2015): e0128447.;;Wang, Jian, et al. “Electrical stimulation of cerebellar fastigial nucleus: mechanism of neuroprotection and prospects for clinical application against cerebral ischemia.” CNS neuroscience & therapeutics 20.8 (2014): 710-716.;;Winship, Ian R. “Cerebral collaterals and collateral therapeutics for acute ischemic stroke.” Microcirculation 22.3 (2015): 228-236.;;Xiang, Yao-xian, et al. “Electrical stimulation of the vagus nerve protects against cerebral ischemic injury through an anti-infammatory mechanism.” Neural regeneration research 10.4 (2015): 576.;;Zhang, Lei, Mingkui Zhao, and Ru-Bo Sui. “Cerebellar fastigial nucleus electrical stimulation alleviates depressive-like behaviors in post-stroke depression rat model and potential mechanisms.” Cellular Physiology and Biochemistry 41.4 (2017): 1403-1412.;;Zhou, Long, et al. “Neuroprotective effects of vagus nerve stimulation on traumatic brain injury.” Neural regeneration research 9.17 (2014): 1585.;;Zhou, Ping, et al. “Electrical stimulation of cerebellar fastigial nucleus protects rat brain, in vitro, from staurosporine-induced apoptosis.” Journal of neurochemistry 79.2 (2001): 328-338.;;Zhou, Ping, et al. “Mitochondria are involved in the neurogenic neuroprotection conferred by stimulation of cerebellar fastigial nucleus.” Journal of neurochemistry 95.1 (2005): 221-229.",ACTIVE
2,US,A1,US 2020/0360683 A1,165-944-352-481-680,2020-11-19,2020,US 201816762542 A,2018-11-09,US 201816762542 A;;US 201762583778 P;;US 2018/0059993 W,2017-11-09,NEUROSTIMULATION INDUCED MEDICINE DEVICES AND RELATED METHODS OF USE,"Example neurostimulation induced medicine devices and methods of use are described herein. An example endotracheal device can include an elongate tubular member having a proximal end and a distal end, an inflatable cuff arranged between the proximal and distal ends of the elongate tubular member, and an electrode array disposed in proximity to an exterior surface of the inflatable cuff. The inflatable cuff can be configured to expand to contact a subject's tracheal wall. Additionally, the electrode array can include a plurality of flexible electrodes, where a set of the flexible electrodes anatomically align with a region of the subject's tracheal wall for selectively targeting vagus nerve activity.",THE METHODIST HOSPITAL SYSTEM,GOLANOV EUGENE V;;BRITZ GAVIN W;;HORNER PHILIP JOHN;;WOLFE TATIANA,THE METHODIST HOSPITAL SYSTEM (2020-09-25),https://lens.org/165-944-352-481-680,Patent Application,yes,0,0,3,3,0,A61N1/0517;;A61N1/36053;;A61M16/045;;A61N1/3614;;A61N1/086;;A61M16/0488;;A61N1/0519;;A61N1/36053,A61M16/04;;A61N1/05;;A61N1/08;;A61N1/36,,0,0,,,,ACTIVE
3,WO,A1,WO 2019/094698 A1,032-363-994-764-959,2019-05-16,2019,US 2018/0059993 W,2018-11-09,US 201762583778 P,2017-11-09,NEUROSTIMULATION INDUCED MEDICINE DEVICES AND RELATED METHODS OF USE,"Example neurostimulation induced medicine devices and methods of use are described herein. An example endotracheal device can include an elongate tubular member having a proximal end and a distal end, an inflatable cuff arranged between the proximal and distal ends of the elongate tubular member, and an electrode array disposed in proximity to an exterior surface of the inflatable cuff. The inflatable cuff can be configured to expand to contact a subject's tracheal wall. Additionally, the electrode array can include a plurality of flexible electrodes, where a set of the flexible electrodes anatomically align with a region of the subject's tracheal wall for selectively targeting vagus nerve activity.",THE METHODIST HOSPITAL SYSTEM,GOLANOV EUGENE V;;BRITZ GAVIN W;;HORNER PHILIP JOHN;;WOLFE TATIANA,,https://lens.org/032-363-994-764-959,Patent Application,yes,3,1,3,3,0,A61N1/0517;;A61N1/36053;;A61M16/045;;A61N1/3614;;A61N1/086;;A61M16/0488;;A61N1/0519;;A61N1/36053,A61N1/04;;A61N1/18,,0,0,,,,PENDING
4,WO,A1,WO 2022/226155 A1,133-679-968-281-50X,2022-10-27,2022,US 2022/0025703 W,2022-04-21,US 202163178616 P,2021-04-23,SYSTEMS AND METHODS FOR IMPROVING CEREBROSPINAL FLUID (CSF) DRAINAGE,"Systems and methods for draining cerebrospinal fluid (CSF) are described herein described herein. In one implementation, an example system includes a signal generator, a plurality of electrodes operably connected to the signal generator, and a controller operably connected to the signal generator. The controller includes a processor and a memory. The controller is configured to deliver a neuromuscular electrical stimulation signal including at least one burst of pulses to at least one muscle in the subject's neck. The neuromuscular electrical stimulation signal is configured to induce a plurality of contractions of the at least one muscle. Additionally, the contractions of the at least one muscle are configured to squeeze at least one lymph node to create a pumping force, and the pumping force is configured to direct CSF flow in a proximal direction. The results in CSF drainage through the subject's neck lymphatic system.",THE METHODIST HOSPITAL SYSTEM,GOLANOV EUGENE V;;REGNIER-GOLANOV ANGELIQUE S;;KARMONIK CHRISTOF;;BRITZ GAVIN W;;ESKURI ALAN DAVID,,https://lens.org/133-679-968-281-50X,Patent Application,yes,5,0,1,1,0,A61M1/80;;A61N1/36014;;A61N1/36034;;A61N1/0452;;A61N1/0476;;A61N1/0492;;A61N1/0504;;A61N1/0456;;A61N1/3605;;A61N1/36031;;A61M27/006;;A61M60/882;;A61B5/389;;A61B5/1107,A61N1/36;;A61N1/04,,0,0,,,,PENDING
